Skip to main content
Premium Trial:

Request an Annual Quote

Ciphergen s SELDI Tech Helps Harvard Team Identify Likely Cancer Biomarker

NEW YORK, April 8 - Researchers at Harvard University have used protein-chip technology developed by Ciphergen Biosystems to identify a biomarker that might lead to faster detection of ovarian cancer.

The researchers showed that a certain protein peak was elevated in a majority of women with ovarian cancer whose sera was obtained and screened by Ciphergen's SELDI technology. The team identified this protein to be the alpha chain of haptoglobin.

Using the SELDI platform again to screen a number of these sera samples, the researchers recorded 90 percent specificity and 71 percent sensitivity when using the haptoglobin peak as the diagnostic criterion. This diagnostic accuracy exceeds that of any currently available blood test for ovarian cancer, the scientists said.


"We found that alpha subunit of the haptoglobin protein was elevated in serum samples across patients with different subtypes of ovarian tumors, and less so across the healthy control samples, suggesting that this protein may represent a novel marker, which may be used to detect ovarian cancer," Samuel Mok, director of the Laboratory of Gynecologic Oncology at the Brigham & Women's Hospital, Harvard Medical School, said in a Ciphergen statement.

The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.